GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.132 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
1.132 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
BMX |
IPI00514142 |
1.132 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.132 |
Evidence |
|
TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.132 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
OSM |
OSM: Oncostatin-M precursor |
1.132 |
Evidence |
|
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
1.132 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
1.132 |
Evidence |
|
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
1.132 |
Evidence |
|
OSM |
OSM: Oncostatin-M precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.132 |
Evidence |
|
FN1 |
IPI00339223 |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
1.132 |
Evidence |
|
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
1.132 |
Evidence |
O
|
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
1.132 |
Evidence |
|